Myeloablative Fractionated Busulfan Conditioning Regimen with Venetoclax in Patients with AML/MDS: Prospective Phase II Clinical Trial
暂无分享，去创建一个
M. Konopleva | K. Rezvani | D. Marin | E. Shpall | T. Kadia | B. Andersson | B. Valdez | Y. Nieto | U. Popat | Q. Bashir | M. Qazilbash | A. Alousi | R. Champlin | R. Mehta | C. Hosing | P. Kebriaei | B. Oran | J. Ramdial | G. Alatrash | A. Olson | Jin S Im | S. Srour | N. Saini | A. Gulbis | R. Bassett